secwatch.observer — SEC 8-K summary
======================================

Issuer:     PMGC Holdings Inc. (ELAB)
CIK:        0001840563
Form:       8-K
Filed at:   2026-02-19T23:59:59+00:00
Accession:  0001213900-26-018189
Event type: other_material
Sentiment:  positive
Materiality: 0.55
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PMGC subsidiary files 10 US patent applications for EL-22/EL-32 in animal muscle growth
--------------------------------------------------------------------------------

- NorthStrive Biosciences, wholly owned by PMGC, filed ten US patent applications expanding EL-22 and EL-32 into animal health and agriculture.
- Applications cover EL-22 (5 patents) and EL-32 (5 patents) for livestock, aquaculture, and poultry including muscle growth and yield.
- Two applications target livestock muscle growth: EL-22 (19/541,209) and EL-32 (19/540,888).
- Additional filings address emissions reduction in livestock and aquaculture, and poultry muscle development.
- This expands PMGC's IP portfolio beyond human aesthetic medicine into animal agriculture markets.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1840563/000121390026018189/0001213900-26-018189-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1840563/000121390026018189/ea0277555-8k_pmgc.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-018189

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer